Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

124
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
124
Altered States of Awareness01:06

Altered States of Awareness

147
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
147
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

194
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
194
Psychodynamic Therapy01:29

Psychodynamic Therapy

56
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
56
High-Level and Low-Level Awareness01:19

High-Level and Low-Level Awareness

247
Controlled processes in human consciousness represent high-alert mental states where individuals deliberately focus their attention on achieving specific goals. Controlled processes can be seen in situations like mastering new technology, where a person might become so absorbed that they ignore surrounding distractions. Such processes involve selective attention, requiring one to concentrate on particular elements of experience while disregarding others. These are governed by executive...
247

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma.

Sociology of health & illness·2026
Same author

'It's Pure Bliss': Pharmaceutical pleasures in later-life use of sleeping medication.

The International journal on drug policy·2026
Same author

Understanding 'embedded pharmaceuticalisation': A case study of sleeping medication use in later life.

Health (London, England : 1997)·2026
Same author

Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samples.

PloS one·2025
Same author

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents.

JTO clinical and research reports·2025
Same author

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab.

Molecular oncology·2025
Same journal

The impact of drug decriminalization policy on mental health- and substance-related service utilization among people who use drugs with prior care in British Columbia.

The International journal on drug policy·2026
Same journal

Surveilled subjectivation: narratives of drug policing among people who use prohibited drugs in Sweden.

The International journal on drug policy·2026
Same journal

"Once I started going… I had this central wheel hub": Drivers of overdose prevention center engagement and connections to care in Rhode Island.

The International journal on drug policy·2026
Same journal

How many traffic fatalities can be attributed to cannabis each year in the US?

The International journal on drug policy·2026
Same journal

Value capture in the emerging medical cannabis global value chain: insights from South Africa.

The International journal on drug policy·2026
Same journal

"Just take it away from them and talk to them about it": exploring youth perspectives on and experiences with cannabis-related school discipline.

The International journal on drug policy·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

4.3K

Towards a dynamic processual model of psychedelic microdosing.

Jason Hughes1, Joshua Stuart-Bennett1, Michael Dunning1

  • 1School of Criminology, Sociology and Social Policy, University of Leicester, UK. AC 2.06, University Road, Leicester, LE1 7RH, UK.

The International Journal on Drug Policy
|December 22, 2024
PubMed
Summary
This summary is machine-generated.

Psychedelic microdosing journeys involve distinct phases, from discovery to integration and advocacy. Understanding these pathways reveals a complex process of personal growth and practice development.

Keywords:
MicrodosingPhasesProcess SociologyPsychedelicsTemporalities

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K

Related Experiment Videos

Last Updated: Jun 4, 2025

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

4.3K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K

Area of Science:

  • Psychoactive substance research
  • Human behavior studies
  • Sociology of drug use

Background:

  • Growing interest in psychedelic microdosing for therapy and self-enhancement.
  • Limited understanding of user pathways into, within, and out of microdosing practices.
  • Need for research on individuals who microdose without prior illicit substance use.

Purpose of the Study:

  • To explore the diverse pathways and processes associated with psychedelic microdosing.
  • To identify distinct phases in the development, maintenance, and cessation of microdosing practices.
  • To understand the 'work' involved in microdosing, including stigma negation and supply management.

Main Methods:

  • Trans-national interview-based study.
  • 23 participants: 19 active microdosers, 3 starting, 1 past user.
  • Phased-based analysis of user journeys.

Main Results:

  • Identified six key phases: Awareness/Discovery, Research/Reframing, Access/Supply, Experimentation/Differentiation, Independence/Incorporation, and Expansion/Advocacy.
  • User pathways are multilinear and differentiated.
  • Microdosing involved significant 'work' related to stigma, supply, dosing, and documentation.

Conclusions:

  • Psychedelic microdosing entails a dynamic, phased process.
  • Journeys can lead to increased temporal/relational expansiveness, independence, and integrated practices.
  • Processual models offer valuable insights into drug-use journeys beyond dependency paradigms.